Researchers have discovered that smoking cannabis can reduce symptoms of Parkinson’s disease, including tremors and pain. 20 patients, at an average of 66 years old, took part in a study, and scored an average of 33 on the Unified Parkinson’s Disease Rating Scale prior to consuming cannabis. The score dropped to 24 just 30 minutes after smoking. Ruth Djaldetti, MD, of Tel Aviv University Israel, who recently presented the discovery at the International Congress on Parkinson’s Disease and Movement Disorders, explained; “We not only saw improvement in tremor in these patients, but also in rigidity and in bradykinesia [slowness of movement cause by the disease]”.
A study recently published in the European Journal of Pharmacology has found that THC, a key component of cannabis, can reduce tissue damage caused by nonsteroidal anti-inflammatory drugs (such as ibuprofen). According to the study, “Nonsteroidal anti-inflammatory drugs (NSAIDs), which are among the most widely used analgesics in the world, cause gastrointestinal inflammation that is potentially life-threatening.”
Researchers at West Virginia University found that when delta9-tetrahydrocannabinol, or THC, was administered to test subjects prior to diclofenac-induced gastric hemorrhaging, the hemorrhaging was lessened, and the damage was significantly reduced.
Research released earlier this year, conducted by the University of Illinois Department of Medicine, found cannabis to be a helpful treatment for sleep apnea, a condition in which an individual’s breathing slows down, or sometimes stops entirely during sleep and immediately after waking from sleep.
In summary, the research found that even minimal amounts of THC – one of the prime compounds of cannabis – greatly decreased the negative effects of sleep apnea, without any noticeable adverse effects.
A new analysis of studies examining the effect marijuana has on a person’s lungs, published in the June issue of the Annals of the American Thoracic Society, has found that those who consume cannabis have no increased risk of lung cancer, and may even have a slightly lowered risk. The research was conducted by Dr. Donald Tashkin, emeritus professor of medicine and Medical Director at Pulmonary Function Laboratory at the David Geffen School of Medicine at University of California.
Legalizing medical cannabis doesn’t lead to an increase in teen usage rates, according to a new study conducted by researchers at the University of Florida College of Medicine.
“Our results suggest that, in the states assessed here, MMLs [medical marijuana laws] have not measurably affected adolescent marijuana use in the first few years after their enactment,” the report concludes.
According to their school magazine, New York University is in the process of studying the impact of psilocybin – a compound found in certain “magic mushrooms” – on cancer-related anxiety as well as patients’ sense of well-being. The study, according to the report, is likely to confirm past research from the UCLA and John Hopkins University which has found that magic mushrooms decrease the anxiety associated with being a cancer-patient, and increases those individuals’ overall well-being.
A new study conducted at the Institute of Molecular Psychiatry at the University of Bonn in Germany has found that cannabis triggers the release of antioxidants, which acts as a cleansing mechanism – resulting in the removal of damaged cells and improving the efficiency of mitochondria, the energy source that powers cells, potentially increasing stamina.
The study, published in Philosophical Transactions Of The Royal Society, states: “Neuroinflammatory processes contributing to the progression of normal brain ageing and to the pathogenesis of neurodegenerative diseases are suppressed by cannabinoids”.
A new study published by the journal Nutrition & Diabetes has found that tetrahydrocannabivarin (THCV) – a compound of cannabis — may combat diabetes by improving an individuals glucose tolerance and insulin sensitivity.
Researchers studied THCV by administering it to obese mice; they found that the cannabis-compound contains several metabolically beneficial effects, which include (but are certainly not limited to) improved liver triglyceride levels, increased insulin sensitivity and increased glucose tolerance.
New research published in the journals Behavioural Brain Research and Experimental Brain Research has found that even miniscule amounts of marijuana may help fight brain damage.
Pharmacologist Josef Sarne of Tel Aviv University, the lead researcher of the study, found that tiny amounts of tetrahydrocannabinol (THC) may protect the brain after injuries from seizures, as well as toxic drug exposure and a lack of oxygen.
Anyone who consumes cannabis on a regular basis knows that it doesn’t make you a dangerous driver. Many people find that it makes them a safer, more focused driver; one that’s more aware of their surroundings and the dangers associated with controlling tons of gasoline-filled metal. Not only has this been an anecdotal truth for as long as cars and cannabis have been paired, science has also been clear that consuming marijuana doesn’t make you a dangerous driver, and may make some people safer drivers. More research is needed, but it’s hard to deny that of the research we have, marijuana hasn’t been found to increase a person’s risk of an accident.
To back this claim up, here’s a list of studies and research conducted on this very topic, some of which were funded by national governments in hopes of different results. (Sources are hyperlinked).